Jacobson Pharma (HKSE:02633) Buyback Yield % : 0.00 (As of May. 03, 2025)

View and export this data going back to 2016. Start your Free Trial

What is Jacobson Pharma Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Jacobson Pharma's current buyback yield was 0.00%.

Jacobson Pharma Buyback Yield % Historical Data

The historical data trend for Jacobson Pharma's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jacobson Pharma Buyback Yield % Chart

Jacobson Pharma Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Buyback Yield %

Get a 7-Day Free Trial

9.16

-11.36

2.45

-2.67

Jacobson Pharma Semi-Annual Data
	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
Buyback Yield %	Get a 7-Day Free Trial															1.93	2.45	0.76	-2.67	-

Competitive Comparison of Jacobson Pharma's Buyback Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Jacobson Pharma's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Jacobson Pharma's Buyback Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jacobson Pharma's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Jacobson Pharma's Buyback Yield % falls into.

Save Embed

;

Save Embed

;

Jacobson Pharma Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Jacobson Pharma's Buyback Yield for the fiscal year that ended in Mar. 2024 is calculated as

Buyback Yield	=	Net Issuance of Stock			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	/	Market Cap
	=	- (0	+	31.213)	/	1168.33039
	=	-2.67%

Jacobson Pharma's annualized Buyback Yield for the quarter that ended in Sep. 2024 is calculated as

Buyback Yield	=	Net Issuance of Stock		(TTM)		/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	(TTM)^**	/	Market Cap
	=	- (0	+	0)		/	1231.14702
	=	0.00%

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Jacobson Pharma Buyback Yield % Related Terms

Thank you for viewing the detailed overview of Jacobson Pharma's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Jacobson Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jacobson Pharma Corp Ltd (HKSE:02633) » Definitions » Buyback Yield %

Traded in Other Exchanges

N/A

Address

388 Kwun Tong Road, Unit 2313-18, 23rd Floor, Tower 1, Millennium City 1, Kwun Tong, Kowloon, Hong Kong, HKG

Website

http://www.jacobsonpharma.com

Jacobson Pharma Corp Ltd is an investment holding company. It is principally engaged in the development, production, marketing, and sale of generic drugs. The company's operating segment includes Generic drugs; Branded healthcare, Wholesale, and retail The generic drugs segment develops, manufactures, and distributes a host of off-patent medicines for various therapeutic use. It generates maximum revenue from the Generic drugs segment. Geographically, it derives a majority of its revenue from Hong Kong and also has a presence in Mainland China, Macau, Singapore, and Other Countries.

Executives

Queenshill Development Limited
Sum Kwong Yip, Derek	2305 Beneficiary of a trust
Lau Wing Hung
Kingshill Development Group Inc
Kingshill Development Limited
Ubs Trustees (b.v.i.) Limited
Longjin Investments Limited
Yun Nan Bai Yao Ji Tuan Gu Fen You Xian Gong Si

Jacobson Pharma Headlines

No Headlines